Tuesday - December 24, 2024

Methods of Treating Urea Cycle Disorders by Interfering With Glucagon Receptor Signaling

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12139546 B2, initially filed Aug. 21, 2018) developed by three inventors Haruka Okamoto, New York, New York; Xiping Cheng, Northvale, New Jersey; and Jesper Gromada, Concord, Massachusetts, for "Methods of treating urea cycle disorders by interfering with glucagon receptor signaling." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Methods of Treating Urea Cycle Disorders by Interfering With Glucagon Receptor Signaling

Information Request Form

Copyright Targeted News Service 2024